Jacobi Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
Jacobi Capital Management's BEAT Position: Q1 2021 in Review
Jacobi Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 396 shares — an estimated $29K sold.
Jacobi Capital Management first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $29K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Jacobi Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Jacobi Capital Management sold 396 BioTelemetry, Inc. shares in Q1 2021, an estimated $29K.
- Jacobi Capital Management first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
- Jacobi Capital Management's BioTelemetry, Inc. position peaked at $29K in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.